Cargando…
Advances in exosome biomarkers for cervical cancer
Cervical cancer (CC) ranks as the fourth most frequently diagnosed malignancy in females worldwide. Exosomes are a subclass of extracellular vesicles released by nearly all types of cells that act as cargo transport vehicles, carrying proteins, and genetic material (such as miRNAs, long noncoding RN...
Autores principales: | Ran, Zihan, Wu, Shaobo, Ma, Zijng, Chen, Xiuwen, Liu, Jing, Yang, Jingcheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761094/ https://www.ncbi.nlm.nih.gov/pubmed/35578572 http://dx.doi.org/10.1002/cam4.4828 |
Ejemplares similares
-
GlioMarker: An integrated database for knowledge exploration of diagnostic biomarkers in gliomas
por: Ran, Zihan, et al.
Publicado: (2022) -
Evaluation of Exosomal miRNA as Potential Biomarkers in Cervical Cancer
por: do Nascimento Medeiros, Jéssika Aline, et al.
Publicado: (2023) -
Advances in Exosomes as Diagnostic and Therapeutic Biomarkers for Gynaecological Malignancies
por: Miao, Mengdan, et al.
Publicado: (2022) -
Exosome: emerging biomarker in breast cancer
por: Jia, Yunlu, et al.
Publicado: (2017) -
Clinical significance of exosomes as potential biomarkers in cancer
por: Wong, Chi-Hin, et al.
Publicado: (2019)